Security key
61023L207
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 25
- Total 13F value
- $2,315
- Share change
- -4
- SEC-reported price per share
- $92.60
- Number of holders
- 1
- Value change
- -$370
- Number of sells
- 1
- Shares outstanding
- 6,646,654
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
MNPR full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Monopar Therapeutics SEC filings
Monopar Therapeutics company facts
Monopar Therapeutics 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 61023L207
Recent filing periods:
Ownership snapshot
Top reported holders of MNPR - Monopar Therapeutics - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JANUS HENDERSON GROUP PLC
Disclosed value leader
JANUS HENDERSON GROUP PLC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 20%
13D/G row: JANUS HENDERSON GROUP PLC
Showing 1-6 of 15 holder rows.
Quick read
JANUS HENDERSON GROUP PLC leads the comparable SEC ownership view at 20%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JANUS HENDERSON GROUP PLC's linked filing trail.
Comparable ownership
Top 5
JANUS HENDERSON GROUP PLC
20%
RA CAPITAL MANAGEMENT, L.P.
9.9%
ASTRAZENECA PLC
7.8%
Adage Capital Management, L.P.
6.2%
Saturn V Capital Management LP
5.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13D/G
13F
Company
|
20%
|
$105,138,701
1,287,368 shares
|
+$9,391,992 | 30 Sep 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
Company
|
9.9%
|
$43,402,756
667,632 shares
|
-$4,890,637 | 31 Dec 2025 |
| ASTRAZENECA PLC |
13D/G
|
7.8%
|
$34,126,392
522,667 shares
|
$0 | 31 Dec 2025 |
| Adage Capital Management, L.P. |
13D/G
|
6.2%
|
$23,788,856
424,195 shares
|
-$9,814,000 | 31 Mar 2026 |
| Saturn V Capital Management LP |
13D/G
13F
Company
|
5.2%
|
$19,382,706
345,626 shares
|
$0 | 05 Jan 2026 |
| Hendricks Diane |
3/4/5
10%+ Owner
|
8.5%
|
$50,213,802
567,580 shares
|
— | 16 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
25
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
82
Q2 2026 holders
1
Holder diff
-81
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend